Sign in
4

Changes in Ownership

Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000089

10% owner bought 500,000 shares at $4.00 ($2,000,000)

  • 10% owner acquired 297,133 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Inscobee Inc. 10% owner 2025-05-12 Purchase +500,000 $4.00 $2,000,000 1,984,616 D
Inscobee Inc. 10% owner 2025-05-12 Conversion +182,002 $2.60 $473,205 4,316,618 I
Inscobee Inc. 10% owner 2025-05-12 Conversion +71,090 $2.60 $184,834 4,387,708 I
Inscobee Inc. 10% owner 2025-05-12 Conversion +44,041 $2.60 $114,507 2,028,657 D
Derivatives
Inscobee Inc. 10% owner 2025-05-12 Conversion · Convertible Promissory Note −0 0 I
Inscobee Inc. 10% owner 2025-05-12 Conversion · Convertible Promissory Note −0 0 I
Inscobee Inc. 10% owner 2025-05-12 Conversion · Convertible Promissory Note −0 0 D
Open-market purchases · 500,000 sh · avg $4.00 · $2,000,000
Loading xslF345X05/primary_doc.xml…